{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:24:39Z","timestamp":1783488279880,"version":"3.55.0"},"reference-count":29,"publisher":"Bioscientifica","issue":"2","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":3918,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background: In Graves' thyrotoxicosis tachycardia, weight loss and mental symptoms are common. Recovery takes time and varies between patients. Treatment with methimazole reduces thyroid hormone levels. According to previous research, this reduction has been faster if selenium (Se) is added. Objective: The objective was to investigate whether supplementing the pharmacologic treatment with Se could change the immune mechanisms, hormone levels and\/or depression and anxiety. Methods: We prospectively investigated 38 patients with initially untreated thyrotoxicosis by measuring the thyroid-stimulating hormone (TSH), free thyroxine (FT&amp;lt;sub&amp;gt;4&amp;lt;\/sub&amp;gt;), free triiodothyronine (FT&amp;lt;sub&amp;gt;3&amp;lt;\/sub&amp;gt;), thyroid receptor antibodies and thyroid peroxidase auto-antibodies before medication and at 6, 18 and 36 weeks after commencing treatment with methimazole and levo-thyroxine, with a randomized blinded oral administration of 200 \u00b5g Se\/day or placebo. The selenoprotein P concentration was determined in plasma at inclusion and after 36 weeks. The patients were also assessed with questionnaires about depression, anxiety and self-rated symptoms before medication was started and after 36 weeks. Results: FT&amp;lt;sub&amp;gt;4&amp;lt;\/sub&amp;gt; decreased more in the Se group at 18 weeks (14 vs. 17 pmol\/l compared to the placebo group, p = 0.01) and also at 36 weeks (15 vs. 18 pmol\/l, p = 0.01). The TSH increased more in the Se group at 18 weeks (0.05 vs. 0.02 mIU\/l, p = 0.04). The depression and anxiety scores were similar in both groups. In the Se group, the depression rates correlated negatively with FT&amp;lt;sub&amp;gt;3&amp;lt;\/sub&amp;gt; and positively with TSH. This was not seen in the placebo group. Conclusions: Se supplementation can enhance biochemical restoration of hyperthyroidism, but whether this could shorten clinical symptoms of thyrotoxicosis and reduce mental symptoms must be investigated further.<\/jats:p>","DOI":"10.1159\/000381768","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T17:02:49Z","timestamp":1432659769000},"page":"93-98","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-17","source":"Crossref","is-referenced-by-count":53,"title":["A Prospective Investigation of Graves' Disease and Selenium: Thyroid Hormones, Auto-Antibodies and Self-Rated Symptoms"],"prefix":"10.1530","volume":"4","author":[{"given":"Jan","family":"Calissendorff","sequence":"first","affiliation":[{"name":"1Department of Clinical Science and Education, Section of Endocrinology, Karolinska Institutet, S\u00f6dersjukhuset, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Mikulski","sequence":"additional","affiliation":[{"name":"3Department of Medicine, M\u00e4larsjukhuset, Eskilstuna, Sweden"},{"name":"4Centre for Clinical Research in S\u00f6rmland, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik H.","family":"Larsen","sequence":"additional","affiliation":[{"name":"5National Food Institute, Technical University of Denmark, S\u00f8borg, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"M\u00f6ller","sequence":"additional","affiliation":[{"name":"2Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden"},{"name":"4Centre for Clinical Research in S\u00f6rmland, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2015,5,27]]},"reference":[{"key":"2026070712454455300_ref1","doi-asserted-by":"crossref","unstructured":"Abraham-Nordling M, Bystrom K, Torring O, Lantz M, Berg G, Calissendorff J, et al: Incidence of hyperthyroidism in Sweden. Eur J Endocrinol 2011;165:899-905.10.1530\/EJE-11-054821908653","DOI":"10.1530\/EJE-11-0548"},{"key":"2026070712454455300_ref2","doi-asserted-by":"crossref","unstructured":"Seigel SC, Hodak SP: Thyrotoxicosis. Med Clin North Am 2012;96:175-201.10.1016\/j.mcna.2012.01.01622443970","DOI":"10.1016\/j.mcna.2012.01.016"},{"key":"2026070712454455300_ref3","doi-asserted-by":"crossref","unstructured":"Benker G, Reinwein D, Kahaly G, et al: Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study. The European Multicenter Trial Group of the Treatment of Hyperthyroidism with Antithyroid Drugs. Clin Endocrinol (Oxf) 1998;49:451-457.10.1046\/j.1365-2265.1998.00554.x9876342","DOI":"10.1046\/j.1365-2265.1998.00554.x"},{"key":"2026070712454455300_ref4","doi-asserted-by":"crossref","unstructured":"Cooper DS: Antithyroid drugs. N England J Med 2005;352:905-917.10.1056\/NEJMra04297215745981","DOI":"10.1056\/NEJMra042972"},{"key":"2026070712454455300_ref5","doi-asserted-by":"crossref","unstructured":"Sundaresh V, Brito JP, Wang Z, Prokop LJ, Stan MN, Murad MH, et al: Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis. J Clin Endocrinol Metab 2013;98:3671-3677.10.1210\/jc.2013-195423824415","DOI":"10.1210\/jc.2013-1954"},{"key":"2026070712454455300_ref6","doi-asserted-by":"crossref","unstructured":"Rayman MP: The argument for increasing selenium intake. Proc Nutr Soc 2002;61:203-215.10.1079\/PNS200215312133202","DOI":"10.1079\/PNS2002153"},{"key":"2026070712454455300_ref7","doi-asserted-by":"crossref","unstructured":"Mostert V, Selenoprotein P: Properties, functions and regulation. Arch Biochem Biophys 2000;376:433-438.10.1006\/abbi.2000.173510775431","DOI":"10.1006\/abbi.2000.1735"},{"key":"2026070712454455300_ref8","doi-asserted-by":"crossref","unstructured":"Diez D, Grijota-Martinez C, Agretti P, De Marco G, Tonacchera M, Pinchera A, et al: Thyroid hormone action in the adult brain: gene expression profiling of the effects of single and multiple doses of triiodo-&lt;span style=\"font-variant:small-caps; text-transform:lowercase\"&gt;L&lt;\/span&gt;-thyronine in the rat striatum. Endocrinology 2008;149:3989-4000.10.1210\/en.2008-035018467437","DOI":"10.1210\/en.2008-0350"},{"key":"2026070712454455300_ref9","doi-asserted-by":"crossref","unstructured":"Hagenbuch B: Cellular entry of thyroid hormones by organic anion transporting polypeptides. Best Pract Res Clin Endocrinol Metab 2007;21:209-221.10.1016\/j.beem.2007.03.00417574004","DOI":"10.1016\/j.beem.2007.03.004"},{"key":"2026070712454455300_ref10","doi-asserted-by":"crossref","unstructured":"St Germain DL: Selenium deiodinases and endocrine function; in Hatfield DL (ed): Selenium. Its Molecular Biology and Role in Human Health. Boston, Kluwer Academic Publishers, 2001, pp 189-205.10.1007\/978-1-4615-1609-5_16","DOI":"10.1007\/978-1-4615-1609-5_16"},{"key":"2026070712454455300_ref11","doi-asserted-by":"crossref","unstructured":"Levi Y, Rassovsky Y, Agranov E, Sela-Kaufman M, Vakil E: Cognitive reserve components as expressed in traumatic brain injury. J Int Neuropsychol Soc 2013;19:1-8.10.1017\/S135561771300019223575273","DOI":"10.1017\/S1355617713000192"},{"key":"2026070712454455300_ref12","doi-asserted-by":"crossref","unstructured":"Kesler SR, Adams HF, Blasey CM, Bigler ED: Premorbid intellectual functioning, education, and brain size in traumatic brain injury: an investigation of the cognitive reserve hypothesis. Appl Neuropsychol 2003;10:153-162.10.1207\/S15324826AN1003_0412890641","DOI":"10.1207\/S15324826AN1003_04"},{"key":"2026070712454455300_ref13","doi-asserted-by":"crossref","unstructured":"Eskes SA, Endert E, Fliers E, Birnie E, Hollenbach B, Schomburg L, et al: Selenite supplementation in euthyroid subjects with thyroid peroxidase antibodies. Clin Endocrinol (Oxf) 2014;80:444-451.10.1111\/cen.1228423844613","DOI":"10.1111\/cen.12284"},{"key":"2026070712454455300_ref14","doi-asserted-by":"crossref","unstructured":"Bonfig W, G\u00e4rtner R, Schmidt H: Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis. ScientificWorldJournal 2010;10:990-996.10.1100\/tsw.2010.9120526530","DOI":"10.1100\/tsw.2010.91"},{"key":"2026070712454455300_ref15","doi-asserted-by":"crossref","unstructured":"Vrca VB, Skreb F, Cepelak I, Romic Z, Mayer L: Supplementation with antioxidants in the treatment of Graves\u00b4disease: the effect on glutathione peroxidase activity and concentration of selenium. Clin Chim Acta 2004;341:55-63.10.1016\/j.cccn.2003.10.02814967159","DOI":"10.1016\/j.cccn.2003.10.028"},{"key":"2026070712454455300_ref16","doi-asserted-by":"crossref","unstructured":"Larsen EH, Hansen M, Paulin H, Moesgaard S, Reid M, Rayman M: Speciation and bioavailability of selenium in yeast-based intervention agents used in cancer chemoprevention studies. J AOAC Int 2004;87:225-232.15084104","DOI":"10.1093\/jaoac\/87.1.225"},{"key":"2026070712454455300_ref17","doi-asserted-by":"crossref","unstructured":"King NS, Crawford S, Wenden FJ, Moss NE, Wade DT: The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J Neurol 1995;242:587-592.10.1007\/BF008688118551320","DOI":"10.1007\/BF00868811"},{"key":"2026070712454455300_ref18","doi-asserted-by":"crossref","unstructured":"Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.10.1111\/j.1600-0447.1983.tb09716.x6880820","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"2026070712454455300_ref19","unstructured":"Loeschner K, Hadrup N, Hansen M, Pereira SA, Gammelgaard B, M\u00f8ller LH, et al: Absorption, distribution, metabolism and excretion of selenium following oral administration of elemental selenium or selenite in rats. Metallomics 2014;6:330-337.10.1039\/c3mt00309d24413471"},{"key":"2026070712454455300_ref20","doi-asserted-by":"crossref","unstructured":"Stern Y: What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002;8:448-460.10.1017\/S135561770281324811939702","DOI":"10.1017\/S1355617702813248"},{"key":"2026070712454455300_ref21","doi-asserted-by":"crossref","unstructured":"Ravn-Haren G, Krath BN, Overvad K, Cold S, Moesgaard S, Larsen EH, et al: Effect of long-term selenium yeast intervention on activity and gene expression of antioxidant and xenobiotic metabolising enzymes in healthy elderly volunteers from the Danish Prevention of Cancer by Intervention by Selenium (PRECISE) pilot study. Br J Nutr 2008;99:1190-1198.10.1017\/S000711450788294818062829","DOI":"10.1017\/S0007114507882948"},{"key":"2026070712454455300_ref22","doi-asserted-by":"crossref","unstructured":"Xia Y, Hill KE, Byrne DW, Xu J, Burk RF: Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr 2005;81:829-834.15817859","DOI":"10.1093\/ajcn\/81.4.829"},{"key":"2026070712454455300_ref23","doi-asserted-by":"crossref","unstructured":"Huang Z, Rose AH, Hoffmann PR: The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2012;16:705-743.10.1089\/ars.2011.414521955027","DOI":"10.1089\/ars.2011.4145"},{"key":"2026070712454455300_ref24","doi-asserted-by":"crossref","unstructured":"Hoffman FW, Hashimoto AC, Shafer LA, Dow S, Berry MJ, Hoffman PR: Dietary selenium modulates activation and differentiation of CD+4 T-cells in mice through a mechanism involving cellular free thiols. J Nutr 2010;140:1155-1161.10.3945\/jn.109.12072520375261","DOI":"10.3945\/jn.109.120725"},{"key":"2026070712454455300_ref25","doi-asserted-by":"crossref","unstructured":"Rayman MP: The importance of selenium to human health. Lancet 2000;356:233-241.10.1016\/S0140-6736(00)02490-910963212","DOI":"10.1016\/S0140-6736(00)02490-9"},{"key":"2026070712454455300_ref26","doi-asserted-by":"crossref","unstructured":"Abalovich M, Llesuy S, Gutierrez S, Repetto M: Peripheral parameters of oxidative stress in Graves' disease: the effects of methimazole and 131 iodine treatments. Clin Endocrinol (Oxf) 2003;59:321-327.10.1046\/j.1365-2265.2003.01850.x12919155","DOI":"10.1046\/j.1365-2265.2003.01850.x"},{"key":"2026070712454455300_ref27","doi-asserted-by":"crossref","unstructured":"K\u00f6hrle J, G\u00e4rtner R: Selenium and thyroid. Best Pract Res Clin Endocrinol Metab 2009;23:815-827.10.1016\/j.beem.2009.08.00219942156","DOI":"10.1016\/j.beem.2009.08.002"},{"key":"2026070712454455300_ref28","doi-asserted-by":"crossref","unstructured":"Schomburg L, K\u00f6hrle J: On the importance of selenium and iodine metabolism for thyroid hormone biosynthesis and human health. Mol Nutr Food Res 2008;52:1235-1246.10.1002\/mnfr.20070046518686295","DOI":"10.1002\/mnfr.200700465"},{"key":"2026070712454455300_ref29","doi-asserted-by":"crossref","unstructured":"Toulis KA, Anastasilakis AD, Tzellos TG, Goulis DG, Kuvelas D: Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis. Thyroid 2010;20:1163-1173.10.1089\/thy.2009.035120883174","DOI":"10.1089\/thy.2009.0351"}],"container-title":["European Thyroid Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/381768","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/4\/2\/93\/29122\/etj381768.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article-pdf\/4\/2\/93\/29122\/etj381768.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:01:20Z","timestamp":1783443680000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/etj\/article\/4\/2\/93\/3969\/A-Prospective-Investigation-of-Graves-Disease-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,27]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.1159\/000381768","relation":{},"ISSN":["2235-0802","2235-0640"],"issn-type":[{"value":"2235-0802","type":"electronic"},{"value":"2235-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5,27]]}}}